 | | PRD_002482 | | Name: | cyclic peptide MP-9903 | | Formula: | C71 H108 N17 O20 S2 | | Definition date: | 2021-09-22 | | Last modified: | 2023-11-03 |
|
 | | PRD_000180 | | Name: | Antipain | | Formula: | C27 H46 N10 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002489 | | Name: | lipid II mimetic, LPATA: Thr-in conformation | | Formula: | C53 H85 N14 O16 | | Definition date: | 2022-09-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000183 | | Name: | Microcin C7 | | Formula: | C28 H49 N12 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000197 | | Name: | ALPHA LICHENICIDIN PREPEPTIDE | | Formula: | C142 H226 N36 O41 S5 | | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002510 | | Name: | Minihepcidin PR73 | | Formula: | C86 H136 N21 O15 S | | Definition date: | 2022-12-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_000198 | | Name: | BETA LICHENICIDIN PREPEPTIDE | | Formula: | C133 H200 N36 O37 S4 | | Description: | LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL
MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND
SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS
WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS.
THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE
MODIFIED PRECURSOR. | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000212 | | Name: | Microcystin LR | | Formula: | C49 H75 N10 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000213 | | Name: | motuporin | | Formula: | C40 H57 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000214 | | Name: | NODULARIN-R | | Formula: | C41 H61 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000215 | | Name: | DIHYDROMICROCYSTIN-LA | | Formula: | C46 H69 N7 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000988 | | Name: | N-benzoyl-L-norleucyl-6-ammonio-L-norleucyl-N~5~-[amino(iminio)methyl]-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-ornithinamide | | Formula: | C31 H57 N11 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000224 | | Name: | Polytheonamide B | | Formula: | C219 H376 N60 O72 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001016 | | Name: | Glidobactin | | Formula: | C27 H46 N4 O6 | | Definition date: | 2013-02-06 | | Last modified: | 2023-11-03 |
|
 | | PRD_001018 | | Name: | Cepafungin I | | Formula: | C28 H48 N4 O6 | | Definition date: | 2013-02-06 | | Last modified: | 2023-11-03 |
|
 | | PRD_001021 | | Name: | INHIBITOR ARC-670 | | Formula: | C53 H103 N31 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001022 | | Name: | (2S,5S,8S,13S,16Z)-5-benzyl-2-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxylic acid | | Formula: | C36 H46 N8 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001023 | | Name: | (2S,5S,8S,13S,16Z)-5-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-2-(3-phenylprop-2-en-1-yl)-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxamide | | Formula: | C38 H49 N9 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001025 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H107 N18 O19 S2 | | Definition date: | 2013-10-09 | | Last modified: | 2023-11-03 |
|
 | | PRD_001031 | | Name: | Microcystin-LR (MCLR) bound form | | Formula: | C49 H77 N10 O12 | | Definition date: | 2013-05-08 | | Last modified: | 2023-11-03 |
|
 | | PRD_001041 | | Name: | TMC-95A mimic ligand yCP:4e | | Formula: | C61 H83 N9 O10 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001044 | | Name: | TMC-95A mimic ligand yCP:3a | | Formula: | C60 H80 N8 O11 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001047 | | Name: | (2E,4E)-N-[(2R,3S)-1-{[(5S,8S,9E)-2,7-dioxo-5-(propan-2-yl)-1,6-diazacyclododec-9-en-8-yl]amino}-3-hydroxy-1-oxobutan-2-yl]dodeca-2,4-dienamide | | Formula: | C29 H48 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001049 | | Name: | TMC-95A mimic ligand yCP:4a chain Q | | Formula: | C55 H72 N8 O9 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001066 | | Name: | Muramyl tetrapeptide | | Formula: | C30 H53 N8 O13 | | Definition date: | 2014-03-12 | | Last modified: | 2023-11-03 |
|
